{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:16:18Z","timestamp":1784124978611,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01018-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:47:33Z","timestamp":1784123253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FDA Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites: Testing Presence, Prominence, and Wording"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-7554","authenticated-orcid":false,"given":"Helen W.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie C.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"1018_CR1","unstructured":"Federal Food, Drug, and Cosmetic Act, sec. 506(c)."},{"key":"1018_CR2","unstructured":"C.F.R., sec. 314, subpart H."},{"key":"1018_CR3","unstructured":"C.F.R., sec. 601, subpart E."},{"key":"1018_CR4","unstructured":"Food and Drug Administration. Guidance for industry: expedited programs for serious conditions\u2014drugs and biologics. 2014. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM358301.pdf Accessed 24 October 2025."},{"key":"1018_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaoncol.2017.5618","volume":"4","author":"JA Beaver","year":"2018","unstructured":"Beaver JA, Howie LJ, Pelosof L, Kim T, Liu J, Goldberg KB, et al. A 25-year experience of US Food and Drug Administration accelerated approval of malignant hematology and oncology drugs and biologics: a review. JAMA Oncol. 2018;4:849\u201356.","journal-title":"JAMA Oncol"},{"key":"1018_CR6","unstructured":"C.F.R., sec. 201.57(c)(2)(i)(B)."},{"key":"1018_CR7","unstructured":"US Food and Drug Administration. Labeling for human prescription drug and biological products approved under the accelerated approval pathway guidance for industry. 2019. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM390058.pdf. Accessed 24 October 2025."},{"key":"1018_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/pds.4664","volume":"27","author":"HW Sullivan","year":"2018","unstructured":"Sullivan HW, O\u2019Donoghue AC, David KT, Patel NJ. Disclosing accelerated approval on direct-to-consumer prescription drug websites. Pharmacoepidemiol Drug Saf. 2018;27:1277\u201380.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1018_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1001\/archinternmed.2011.396","volume":"171","author":"LM Schwartz","year":"2011","unstructured":"Schwartz LM, Woloshin S. Communicating uncertainties about prescription drugs to the public: a national randomized trial. Arch Intern Med. 2011;171:1463\u20138.","journal-title":"Arch Intern Med"},{"key":"1018_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-025-02774-0","author":"HW Sullivan","year":"2025","unstructured":"Sullivan HW, O\u2019Donoghue AC, Johnson M. Cancer survivors\u2019 and caregivers\u2019 understanding of FDA accelerated approval disclosures. J Cancer Educ. 2025. https:\/\/doi.org\/10.1007\/s13187-025-02774-0.","journal-title":"J Cancer Educ"},{"key":"1018_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13187-016-1107-1","volume":"33","author":"HW Sullivan","year":"2018","unstructured":"Sullivan HW, Aikin KJ, Squiers LB. Quantitative information on oncology prescription drug websites. J Cancer Educ. 2018;33:371\u20134.","journal-title":"J Cancer Educ"},{"key":"1018_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1634\/theoncologist.2020-0402","volume":"25","author":"HW Sullivan","year":"2020","unstructured":"Sullivan HW, O\u2019Donoghue AC, Ferriola\u2010Bruckenstein K, Tzeng JP, Boudewyns V. Patients\u2019 understanding of oncology clinical endpoints: environmental scan and focus groups. Oncologist. 2020;25:1060\u20136.","journal-title":"Oncologist"},{"key":"1018_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.sapharm.2020.07.028","volume":"17","author":"BJ Kelly","year":"2021","unstructured":"Kelly BJ, Rupert DJ, Aikin KJ, Sullivan HW, Johnson M, Bann CM, et al. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Res Soc Admin Pharm. 2021;17:942\u201355.","journal-title":"Res Soc Admin Pharm"},{"key":"1018_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-7-21","volume":"7","author":"NS Morris","year":"2006","unstructured":"Morris NS, MacLean CD, Chew LD, Littenberg B. The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract. 2006;7:21.","journal-title":"BMC Fam Pract"},{"key":"1018_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/19312450802062380","volume":"2","author":"BG Southwell","year":"2008","unstructured":"Southwell BG, Langteau R. Age, memory changes, and the varying utility of recognition as a media effects pathway. Commun Methods Meas. 2008;2:100\u201314.","journal-title":"Commun Methods Meas"},{"key":"1018_CR16","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1093\/oncolo\/oyad064","volume":"28","author":"HW Sullivan","year":"2023","unstructured":"Sullivan HW, O\u2019Donoghue AC, Boudewyns V, Paquin RS, Ferriola-Bruckenstein K. Patient understanding of oncology clinical trial endpoints in direct-to-consumer television advertising. Oncologist. 2023;28:e542.","journal-title":"Oncologist"},{"issue":"S7","key":"1018_CR17","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/cncr.23653","volume":"113","author":"AL Back","year":"2008","unstructured":"Back AL, Anderson WG, Bunch L, Marr LA, Wallace JA, Yang HB, et al. Communication about cancer near the end of life. Cancer. 2008;113(S7):1897\u2013910.","journal-title":"Cancer"},{"key":"1018_CR18","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.pec.2020.03.018","volume":"103","author":"V Boudewyns","year":"2020","unstructured":"Boudewyns V, Southwell BG, DeFrank JT, Ferriola-Bruckenstein K, Halpern MT, O\u2019Donoghue AC, et al. Patients\u2019 understanding of oncology clinical endpoints: a literature review. Patient Educ Couns. 2020;103:1724\u201335.","journal-title":"Patient Educ Couns"},{"key":"1018_CR19","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/hex.13822","volume":"26","author":"M Edwards","year":"2023","unstructured":"Edwards M, Holland\u2010Hart D, Mann M, Seddon K, Buckle P, Longo M, et al. Understanding how shared decision\u2010making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: a realist review. Health Expect. 2023;26:2109\u201326.","journal-title":"Health Expect"},{"key":"1018_CR20","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","volume":"24","author":"R Matsuyama","year":"2006","unstructured":"Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006;24:3490\u20136.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1018_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.sapharm.2017.07.015","volume":"14","author":"KR Betts","year":"2018","unstructured":"Betts KR, Boudewyns V, Aikin KJ, et al. Serious and actionable risks, plus disclosure: investigating an alternative approach for presenting risk information in prescription drug television advertisements. Res Social Adm Pharm. 2018;14(10):951\u201363. https:\/\/doi.org\/10.1016\/j.sapharm.2017.07.015.","journal-title":"Res Social Adm Pharm"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01018-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:47:34Z","timestamp":1784123254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01018-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":21,"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01018-7","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}